Clin2
NCT07374588Likely a fitCompleted

Medication education for better adherence and fewer side effects

SchizophreniaSchizoaffective DisorderBipolar Disorder With Psychotic FeaturesMajor Depressive Disorder With Psychotic Features

Part of Mental health clinical trials.

This trial tests whether teaching hospitalized psychiatric patients about their medications helps them stick to their treatment plan and reduces side effects. If you've been hospitalized with a serious mental illness and are stable enough to attend group sessions, this study may be a good fit for you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
64 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • You are currently staying in a psychiatric inpatient unit
  • You have been diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar disorder with psychotic features, or major depression with psychotic features
  • You are taking medication for your mental health condition
  • You are stable enough to take part in educational sessions and can understand the material
  • You can give written consent to participate

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07488156Not yet recruiting
Improving health understanding in schizophrenia patients

This study tests a program to help people with schizophrenia spectrum disorder better understand their health. Participation involves health literacy assessments and IQ testing during a hospital stay at University Medical Center in New Orleans.

New Orleans, Louisiana
NCT05329363Recruiting
Early psychoeducation for people with schizophrenia or related disorders

This study tests a structured early educational program (“psychoeducation”) given to inpatients to help them understand their condition and cope. It may help people feel more informed and better supported during treatment.

Blois
NCT05416658Not yet recruiting
Helping you make decisions about antipsychotic medicines

This study tests a “shared decision-making” approach to help you and your clinic choose how to use antipsychotic medicines. It may help you feel more involved in decisions if you’re currently taking an antipsychotic, recently stopped, or are thinking about stopping.

NCT06740890Recruiting· Phase 4
Exercise and a new medication for schizophrenia or bipolar disorder

This study tests whether a combination of a daily medication (olanzapine-samidorphan) and a structured exercise program can help people with schizophrenia, schizoaffective disorder, or bipolar disorder improve their health and well-being.

New York, New York
NCT07586150Not yet recruiting
Personalized Treatment for Serious Mental Illness

This study tests whether combining medicine adjustments, lifestyle changes (like diet and exercise), and optional brain stimulation can help people with schizophrenia, bipolar disorder, or depression feel better and function more independently. It may include a weight-loss medication if you're overweight or obese.

Vienna
NCT07098169Recruiting
Testing a program to improve self-awareness for schizophrenia

This trial tests a program called iTEST that helps people with schizophrenia or schizoaffective disorder improve how accurately they understand their own thoughts. The program combines device use with feedback from a clinician or loved one to support better self-awareness.

San Diego, California

Hear when a new Schizophrenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.